MERRIMACK PHARMACEUTICALS INC Quarterly General and Administrative Expense in USD from Q1 2011 to Q1 2024

Taxonomy & unit: us-gaap: USD
Description: The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Summary: Merrimack Pharmaceuticals Inc quarterly/annual General and Administrative Expense history and growth rate from Q1 2011 to Q1 2024.
Merrimack Pharmaceuticals Inc General and Administrative Expense for the quarter ending March 31, 2024 was $669K, a 14.2% increase year-over-year.
Merrimack Pharmaceuticals Inc General and Administrative Expense for the twelve months ending March 31, 2024 was $2.26M, a 3.48% increase year-over-year.
Merrimack Pharmaceuticals Inc annual General and Administrative Expense for 2023 was $2.18M, a 0.09% increase from 2022.
Merrimack Pharmaceuticals Inc annual General and Administrative Expense for 2022 was $2.17M, a 16.9% decline from 2021.
Merrimack Pharmaceuticals Inc annual General and Administrative Expense for 2021 was $2.62M, a 47.8% decline from 2020.

General and Administrative Expense, Trailing 12 Months (USD)

General and Administrative Expense, Quarterly (USD)

General and Administrative Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q1 2024	$2.26M	$669K	+$83K	+14.2%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-15
Q4 2023	$2.18M	$490K	-$117K	-19.3%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-07
Q3 2023	$2.29M	$531K	+$27K	+5.36%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-02
Q2 2023	$2.27M	$569K	+$83K	+17.1%	Apr 1, 2023	Jun 30, 2023	10-Q	2023-08-03
Q1 2023	$2.18M	$586K	+$9K	+1.56%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-15
Q4 2022	$2.17M	$607K	+$134K	+28.3%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-07
Q3 2022	$2.04M	$504K	-$115K	-18.6%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-02
Q2 2022	$2.16M	$486K	-$292K	-37.5%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-03
Q1 2022	$2.45M	$577K	-$169K	-22.7%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-04
Q4 2021	$2.62M	$473K	-$413K	-46.6%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-09
Q3 2021	$3.03M	$619K	-$388K	-38.5%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-03
Q2 2021	$3.42M	$778K	-$406K	-34.3%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-04
Q1 2021	$3.82M	$746K	-$1.19M	-61.4%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-05
Q4 2020	$5.01M	$886K	-$1.33M	-59.9%	Oct 1, 2020	Dec 31, 2020	10-K	2022-03-09
Q3 2020	$6.34M	$1.01M	-$3.34M	-76.8%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-04
Q2 2020	$9.68M	$1.18M	-$4.75M	-80%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-05
Q1 2020	$14.4M	$1.94M	-$1.75M	-47.5%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-06
Q4 2019	$16.2M	$2.21M	-$1.83M	-45.3%	Oct 1, 2019	Dec 31, 2019	10-K	2021-03-10
Q3 2019	$18M	$4.35M	+$569K	+15.1%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-04
Q2 2019	$17.4M	$5.93M	+$2.42M	+68.8%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-07
Q1 2019	$15M	$3.68M	-$587K	-13.7%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-07
Q4 2018	$15.6M	$4.04M	-$613K	-13.2%	Oct 1, 2018	Dec 31, 2018	10-K	2019-03-06
Q3 2018	$16.2M	$3.78M	+$411K	+12.2%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-12
Q2 2018	$15.8M	$3.51M	-$11.3M	-76.3%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-07-17
Q1 2018	$27.1M	$4.27M	-$1.36M	-24.2%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-10
Q4 2017	$28.5M	$4.65M	-$6.36M	-57.7%	Oct 1, 2017	Dec 31, 2017	10-K	2019-03-06
Q3 2017	$34.8M	$3.37M	-$3.08M	-47.8%	Jul 1, 2017	Sep 30, 2017	10-K	2019-03-06
Q2 2017	$37.9M	$14.8M	+$6.66M	+81.8%	Apr 1, 2017	Jun 30, 2017	10-K	2019-03-06
Q1 2017	$31.2M	$5.63M	-$818K	-12.7%	Jan 1, 2017	Mar 31, 2017	10-K	2019-03-06
Q4 2016	$32.1M	$11M	+$3.49M	+46.4%	Oct 1, 2016	Dec 31, 2016	10-K	2018-03-12
Q3 2016	$28.6M	$6.45M	+$459K	+7.66%	Jul 1, 2016	Sep 30, 2016	10-K	2018-03-12
Q2 2016	$28.1M	$8.14M	+$2.31M	+39.7%	Apr 1, 2016	Jun 30, 2016	10-K	2018-03-12
Q1 2016	$25.8M	$6.45M	+$1.74M	+36.9%	Jan 1, 2016	Mar 31, 2016	10-K	2018-03-12
Q4 2015	$24M	$7.52M	+$11M		Oct 1, 2015	Dec 31, 2015	8-K	2017-12-15
Q3 2015	$13.1M	$5.99M	-$2.11M	-26%	Jul 1, 2015	Sep 30, 2015	8-K	2017-12-15
Q2 2015	$15.2M	$5.82M	-$2.1M	-26.5%	Apr 1, 2015	Jun 30, 2015	8-K	2017-12-15
Q1 2015	$17.3M	$4.71M	-$1.51M	-24.3%	Jan 1, 2015	Mar 31, 2015	8-K	2017-12-15
Q4 2014	$18.8M	-$3.47M	-$9.48M	-158%	Oct 1, 2014	Dec 31, 2014	8-K	2017-12-15
Q3 2014	$28.3M	$8.1M	+$2.95M	+57.2%	Jul 1, 2014	Sep 30, 2014	10-Q	2015-11-09
Q2 2014	$25.3M	$7.92M	+$2.83M	+55.5%	Apr 1, 2014	Jun 30, 2014	10-Q	2015-08-10
Q1 2014	$22.5M	$6.22M	+$1.29M	+26.2%	Jan 1, 2014	Mar 31, 2014	10-Q	2015-05-07
Q4 2013	$21.2M	$6.01M	+$1.86M	+44.6%	Oct 1, 2013	Dec 31, 2013	10-K	2015-02-27
Q3 2013	$19.3M	$5.15M	+$838K	+19.4%	Jul 1, 2013	Sep 30, 2013	10-Q	2014-11-10
Q2 2013	$18.5M	$5.1M	+$1.49M	+41.1%	Apr 1, 2013	Jun 30, 2013	10-Q	2014-08-11
Q1 2013	$17M	$4.93M	+$1.2M	+32.3%	Jan 1, 2013	Mar 31, 2013	10-Q	2014-05-06
Q4 2012	$15.8M	$4.16M	+$940K	+29.2%	Oct 1, 2012	Dec 31, 2012	10-K	2015-02-27
Q3 2012	$14.9M	$4.31M	+$1.01M	+30.4%	Jul 1, 2012	Sep 30, 2012	10-Q	2013-11-08
Q2 2012	$13.9M	$3.61M	-$1.22M	-25.3%	Apr 1, 2012	Jun 30, 2012	10-Q	2013-08-08
Q1 2012	$15.1M	$3.73M	+$627K	+20.2%	Jan 1, 2012	Mar 31, 2012	10-Q	2013-05-13
Q4 2011	$14.5M	$3.22M			Oct 1, 2011	Dec 31, 2011	10-K	2014-03-04
Q3 2011		$3.31M			Jul 1, 2011	Sep 30, 2011	10-Q	2012-11-14
Q2 2011		$4.83M			Apr 1, 2011	Jun 30, 2011	10-Q	2012-08-14
Q1 2011		$3.1M			Jan 1, 2011	Mar 31, 2011	10-Q	2012-05-15

* An asterisk sign (*) next to the value indicates that the value is likely invalid.